Keros Therapeutics, Inc.
KROS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001664710
In the last 90 days, Keros Therapeutics, Inc. insiders filed 2 open-market purchases and 4 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $198.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Keros Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 161
- −2 vs. Q3 2024
- Shares held
- 36.7M
- +1.82M (+5.2%) vs. Q3 2024
- Total value
- $582.1M
- −$1.45B (−71.3%) vs. Q3 2024
- New holders
- 38
- 74 more added
- Sold out
- 40
- 30 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KROS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 132 | $198.6M |
| Q1 2026 | 151 | $205.6M |
| Q4 2025 | 166 | $408.4M |
| Q3 2025 | 155 | $558.0M |
| Q2 2025 | 139 | $479.6M |
| Q1 2025 | 156 | $428.6M |
| Q4 2024 | 161 | $582.1M |
| Q3 2024 | 164 | $2.03B |
| Q2 2024 | 152 | $1.44B |
| Q1 2024 | 147 | $2.08B |
| Q4 2023 | 121 | $1.02B |
| Q3 2023 | 107 | $730.6M |
| Q2 2023 | 123 | $901.0M |
| Q1 2023 | 129 | $937.0M |
| Q4 2022 | 126 | $948.2M |
| Q3 2022 | 113 | $680.1M |
| Q2 2022 | 104 | $479.7M |
| Q1 2022 | 106 | $893.0M |
| Q4 2021 | 99 | $944.5M |
| Q3 2021 | 89 | $545.4M |
| Q2 2021 | 80 | $599.7M |
| Q1 2021 | 83 | $887.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Keros Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nebula Research & Development LLC | 71,710 | $1.14M | 0.13% | +58,271+433.6% | Added |
| Y-Intercept (Hong Kong) Ltd | 74,255 | $1.18M | 0.08% | +70,561+1,910.2% | Added |
| Nuveen Asset Management, LLC | 79,485 | $1.26M | 0.00% | −181,863−69.6% | Reduced |
| Sofinnova Investments, Inc. | 95,375 | $1.51M | 0.11% | +95,375 | New |
| Bank of New York Mellon Corp | 97,878 | $1.55M | 0.00% | +2,462+2.6% | Added |
| Engineers Gate Manager LP | 100,017 | $1.58M | 0.03% | +60,348+152.1% | Added |
| Jane Street Group, LLC | 101,112 | $1.60M | 0.00% | +40,934+68.0% | Added |
| Polygon Management Ltd. | 103,000 | $1.63M | 0.53% | +103,000 | New |
| Occudo Quantitative Strategies LP | 103,408 | $1.64M | 0.30% | +103,408 | New |
| PFM Health Sciences, LP | 104,323 | $1.65M | 0.13% | +3,273+3.2% | Added |
| Barclays PLC | 107,542 | $1.70M | 0.00% | +47,528+79.2% | Added |
| Federated Hermes, Inc. | 124,620 | $1.97M | 0.00% | +124,620 | New |
| Twinbeech Capital LP | 129,553 | $2.05M | 0.04% | +114,175+742.5% | Added |
| DAFNA Capital Management LLC | 130,316 | $2.06M | 0.52% | +56,562+76.7% | Added |
| Alliancebernstein L.P. | 137,424 | $2.18M | 0.00% | −20,781−13.1% | Reduced |
| Dimensional Fund Advisors LP | 155,163 | $2.46M | 0.00% | +2,727+1.8% | Added |
| Emerald Mutual Fund Advisers Trust | 155,347 | $2.46M | 0.15% | +42,734+37.9% | Added |
| Bank of America Corp | 161,467 | $2.56M | 0.00% | −9,604−5.6% | Reduced |
| UBS Group AG | 174,941 | $2.77M | 0.00% | +119,034+212.9% | Added |
| Altium Capital Management LP | 175,000 | $2.77M | 0.86% | +106,000+153.6% | Added |
| EcoR1 Capital, LLC | 187,500 | $2.97M | 0.12% | 00.0% | Unchanged |
| Clearbridge Investments, LLC | 190,064 | $3.01M | 0.00% | +190,064 | New |
| Walleye Capital LLC | 197,666 | $3.13M | 0.03% | +197,666 | New |
| Avidity Partners Management LP | 210,000 | $3.32M | 0.33% | −83,200−28.4% | Reduced |
| Susquehanna International Group, LLP | 211,309 | $3.35M | 0.00% | +202,261+2,235.4% | Added |
| JPMorgan Chase & Co | 213,431 | $3.38M | 0.00% | +182,314+585.9% | Added |
| Verition Fund Management LLC | 216,103 | $3.42M | 0.02% | +216,103 | New |
| Balyasny Asset Management LLC | 221,391 | $3.50M | 0.01% | −104,043−32.0% | Reduced |
| Blue Owl Capital Holdings LP | 242,633 | $3.84M | 0.91% | +120,000+97.9% | Added |
| Emerald Advisers, LLC | 244,633 | $3.87M | 0.15% | +89,088+57.3% | Added |
| Boxer Capital Management, LLC | 250,000 | $3.96M | 0.34% | +250,000 | New |
| Charles Schwab Investment Management Inc | 279,682 | $4.43M | 0.00% | +19,562+7.5% | Added |
| Franklin Resources Inc | 288,428 | $4.57M | 0.00% | +194+0.1% | Added |
| Northern Trust Corp | 296,467 | $4.69M | 0.00% | +30,111+11.3% | Added |
| Parkman Healthcare Partners LLC | 314,541 | $4.98M | 0.66% | −107,241−25.4% | Reduced |
| American Century Companies Inc | 328,920 | $5.21M | 0.00% | +31,251+10.5% | Added |
| Eventide Asset Management, LLC | 380,000 | $6.02M | 0.11% | 00.0% | Unchanged |
| Woodline Partners LP | 387,701 | $6.14M | 0.04% | −375,847−49.2% | Reduced |
| Catalio Capital Management, LP | 407,292 | $6.45M | 1.41% | +407,292 | New |
| Integral Health Asset Management, LLC | 450,000 | $7.12M | 0.63% | +250,000+125.0% | Added |
| Goldman Sachs Group Inc | 535,584 | $8.48M | 0.00% | +179,920+50.6% | Added |
| Lynx1 Capital Management LP | 544,001 | $8.61M | 3.23% | +544,001 | New |
| TCG Crossover Management, LLC | 550,000 | $8.71M | 0.85% | −329,344−37.5% | Reduced |
| Redmile Group, LLC | 552,506 | $8.75M | 0.61% | 00.0% | Unchanged |
| Morgan Stanley | 656,801 | $10.4M | 0.00% | +291,504+79.8% | Added |
| Mangrove Partners | 736,385 | $11.7M | 1.39% | +449,390+156.6% | Added |
| Geode Capital Management, LLC | 765,436 | $12.1M | 0.00% | +39,815+5.5% | Added |
| Citadel Advisors LLC | 791,109 | $12.5M | 0.01% | +86,186+12.2% | Added |
| Jefferies Financial Group Inc. | 866,737 | $13.7M | 0.15% | 00.0% | Unchanged |
| Millennium Management LLC | 878,159 | $13.9M | 0.01% | +305,169+53.3% | Added |
| Price T Rowe Associates Inc | 909,707 | $14.4M | 0.00% | −604,798−39.9% | Reduced |
| Nantahala Capital Management, LLC | 915,048 | $14.5M | 1.01% | +533,389+139.8% | Added |
| OrbiMed Advisors LLC | 1,018,734 | $16.1M | 0.33% | 00.0% | Unchanged |
| Alkeon Capital Management LLC | 1,101,000 | $17.4M | 0.10% | −796,601−42.0% | Reduced |
| Holocene Advisors, LP | 1,199,990 | $19.0M | 0.06% | +356,880+42.3% | Added |
| State Street Corp | 1,203,383 | $19.0M | 0.00% | +89,793+8.1% | Added |
| Darwin Global Management, Ltd. | 1,687,135 | $26.7M | 2.53% | +163,403+10.7% | Added |
| Braidwell LP | 1,894,439 | $30.0M | 0.89% | +1,187,199+167.9% | Added |
| Vanguard Group Inc | 1,957,109 | $31.0M | 0.00% | +100,691+5.4% | Added |
| BlackRock, Inc. | 2,729,278 | $43.2M | 0.00% | +96,670+3.7% | Added |
| FMR LLC | 5,543,308 | $87.8M | 0.01% | +644,174+13.1% | Added |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −525,037−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −395,276−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −345,384−100.0% | Sold out |
| Frontier Capital Management Co LLC | 0 | $0 | 0.00% | −287,484−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −224,600−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −199,354−100.0% | Sold out |
| Granahan Investment Management Inc | 0 | $0 | 0.00% | −161,130−100.0% | Sold out |
| WCM Investment Management, LLC | 0 | $0 | 0.00% | −113,860−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −86,930−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −54,236−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −43,500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −27,941−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −26,237−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −25,791−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −24,130−100.0% | Sold out |
| Platinum Investment Management Ltd | 0 | $0 | 0.00% | −20,293−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| B. Metzler seel. Sohn & Co. AG | 0 | $0 | 0.00% | −16,103−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −15,503−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −9,550−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −8,392−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −8,312−100.0% | Sold out |
| Valence8 US LP | 0 | $0 | 0.00% | −8,025−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −7,240−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −5,807−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −4,938−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −4,525−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −3,844−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −3,716−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −3,671−100.0% | Sold out |
| Pictet Asset Management Holding SA | 0 | $0 | 0.00% | −3,527−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −2,058−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −1,528−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −16−100.0% | Sold out |